JUN 15, 2016 1:03 PM PDT

Renal Disease Patients on Dialysis Should Take Blood Pressure Meds

WRITTEN BY: Kara Marker
Doctors often advise late-stage renal disease patients to stop taking blood pressure medications before they reach the stage where they require dialysis to rid the blood of waste, salt, and water. However, a new study published in Nephrology Dialysis Transplantation provides evidence for patients to resume taking these medications in order to reduce the risk of heart disease.
Image credit: www.tynesidekpa.org.uk
 
Taking blood pressure medicine in late-stage renal disease runs the risk of the patient having dangerously high potassium levels, but scientists in this study say that the medications are less risk after a patient has begun receiving peritoneal dialysis. Renal disease patients, who are at a higher risk of developing cardiovascular disease than health people, could benefit from receiving blood pressure medication, mainly angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs), the new study shows.
 
From the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, a team of researchers reviewed almost five thousand medical records of American renal disease patients who began peritoneal dialysis between 2007 and 2011. Of the 42 percent who filled prescriptions for either ACEIs or ARBs, the researchers saw an approximately 16 percent lower risk of heart attack, stroke, and death. Pending the success of randomized clinical trials demonstrating a causal relationship, scientists are prepared to recommend that late-stage renal disease patients undergoing peritoneal dialysis receive either ACEIs or ARBs to reduce their risk of heart disease.
 
“These findings indicate doctors should consider using or re-starting ACEIs and ARBs as first-line blood pressure medications for patients undergoing peritoneal dialysis,” said corresponding author Jenny I. Shen, MD.
 
The kidneys serve to remove waste and excess salt and water from the blood, and certain conditions like diabetes and high blood pressure can cause the kidneys to lose function. End-stage renal disease occurs after chronic kidney disease has persisted for years, and either regular dialysis or a kidney transplant is required for the patient to survive.
 
The researchers in this study looked at renal disease patients who received peritoneal dialysis, a type of treatment that cleanses the blood through a surgical placement of a catheter that releases a fluid called dialysate. This fluid is washed in and out of the body in cycles until the blood-filtering process is finished.
 
ACEIs block the production of a hormone that circulates in the blood, angiotensin II, that is known to cause high blood pressure from constricting the blood vessels. As their name suggests, ARBs also target the function of angiotensin, but in certain cases ARBs might be chosen over ACEIs because they don’t affect the hormone renin like ACEIs do.
 
After the first year of dialysis, more than 20 percent of late-stage renal disease patients die, and almost half of these deaths are because of cardiovascular disease. Re-introducing blood pressure medications for these patients could reduce the prevalence of cardiovascular-related death. Additionally, for chronic kidney disease patients who have not yet reached the late stage, blood pressure medications are also helpful for slowing the progression of kidney damage as well as decreasing risk of cardiovascular disease.
 

 
Sources: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, National Kidney Foundation, MedlinePlus, Circulation, Baylor University Medical Center Proceedings
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 29, 2019
Drug Discovery & Development
JUL 29, 2019
Medications Used for Atrial fibrillation May Increase Falls
Falls among older adults are a growing health concern that often lead to injury, hospitalization, and other severe complications. Older adults are even at...
SEP 10, 2019
Genetics & Genomics
SEP 10, 2019
Gene Mutations Link Flu Infections and Heart Trouble
Sometimes people develop life-threatening heart complications when they're infected with the flu....
SEP 18, 2019
Cardiology
SEP 18, 2019
Clear, Flexible Vital Sign Wearable Monitors
Wearable health monitors are gaining in popularity, both for fitness tracking and for gathering more targeted health data relating to heart disease and oth...
OCT 24, 2019
Cardiology
OCT 24, 2019
Protein Build-Up Places Heart at Risk
Amyloidosis is a disease caused by protein buildup in the body. These abnormal proteins, called amyloids, are produced in the bone marrow. Multiple types o...
DEC 28, 2019
Health & Medicine
DEC 28, 2019
Consider Skipping The Post-Workout Ice Bath
In an effort to get heart-healthy, many people have experienced the painful after-effects of an intense workout. Weather cardiovascular or strength trainin...
JAN 03, 2020
Cardiology
JAN 03, 2020
Healthy Sleep May Offset Genetic Heart Disease Risk
People with a high genetic risk of heart disease or stroke may be able to offset that risk with healthy sleep patterns, according to new research. The rese...
Loading Comments...